KR101590652B1 - 합성 중합체를 사용하여 유전자 사일런싱에 활성이 있는 핵산을 전달하기 위한 수단 - Google Patents

합성 중합체를 사용하여 유전자 사일런싱에 활성이 있는 핵산을 전달하기 위한 수단 Download PDF

Info

Publication number
KR101590652B1
KR101590652B1 KR1020107015535A KR20107015535A KR101590652B1 KR 101590652 B1 KR101590652 B1 KR 101590652B1 KR 1020107015535 A KR1020107015535 A KR 1020107015535A KR 20107015535 A KR20107015535 A KR 20107015535A KR 101590652 B1 KR101590652 B1 KR 101590652B1
Authority
KR
South Korea
Prior art keywords
sirna
composition
tyrosine
rna
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020107015535A
Other languages
English (en)
Korean (ko)
Other versions
KR20100105674A (ko
Inventor
압덴나지 아디브
패트릭 에어바허
파브리스 스톡
나디아 하프디
Original Assignee
뽈리쁠뤼스-트랑스펙씨옹
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뽈리쁠뤼스-트랑스펙씨옹 filed Critical 뽈리쁠뤼스-트랑스펙씨옹
Publication of KR20100105674A publication Critical patent/KR20100105674A/ko
Application granted granted Critical
Publication of KR101590652B1 publication Critical patent/KR101590652B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polyamides (AREA)
KR1020107015535A 2007-12-13 2008-12-12 합성 중합체를 사용하여 유전자 사일런싱에 활성이 있는 핵산을 전달하기 위한 수단 Active KR101590652B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1335807P 2007-12-13 2007-12-13
US61/013,358 2007-12-13

Publications (2)

Publication Number Publication Date
KR20100105674A KR20100105674A (ko) 2010-09-29
KR101590652B1 true KR101590652B1 (ko) 2016-02-18

Family

ID=40561891

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107015535A Active KR101590652B1 (ko) 2007-12-13 2008-12-12 합성 중합체를 사용하여 유전자 사일런싱에 활성이 있는 핵산을 전달하기 위한 수단

Country Status (8)

Country Link
US (1) US20100297756A1 (enExample)
EP (1) EP2229445B1 (enExample)
JP (1) JP5802389B2 (enExample)
KR (1) KR101590652B1 (enExample)
CN (1) CN101952434B (enExample)
CA (1) CA2708354C (enExample)
IL (1) IL206310A (enExample)
WO (1) WO2009074970A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2552460A1 (en) 2010-03-29 2013-02-06 Universite De Strasbourg Polymers for delivering molecules of interest
KR101223483B1 (ko) * 2010-09-10 2013-01-17 한국과학기술연구원 전하결합 및 생분해성 공유결합으로 동시에 연결된 고분자―ｓｉＲＮＡ 나노입자 전달체
KR101497668B1 (ko) * 2012-09-28 2015-03-03 한양대학교 산학협력단 전신 순환을 위한 짧은 간섭 rna 유전자 전달체
WO2014051318A2 (ko) * 2012-09-28 2014-04-03 한양대학교 산학협력단 전신 순환을 위한 짧은 간섭 rna 유전자 전달체
EP4085930A1 (en) 2012-10-05 2022-11-09 BioNTech Delivery Technologies GmbH Hydroxylated polyamine derivatives as transfection reagents for rna
CN104703629B (zh) 2012-10-08 2020-12-01 生物技术传送科技有限责任公司 作为转染试剂的羧化多胺衍生物
CN103087314B (zh) * 2013-02-01 2015-02-18 同济大学 生物可降解聚氨酯基因转染试剂的制备方法
CN107805643B (zh) * 2017-09-15 2020-12-08 四川大学 靶向抑制沙门氏菌耐药外排泵基因acrA的siRNA-DNA纳米系统及其制备方法
BR112022002149A2 (pt) * 2019-08-05 2022-04-19 Polyplus Transfection Composição adequada para transfectar uma molécula de ácido nucleico em uma célula, métodos para transfecção in vitro ou ex vivo de células vivas e para a produção e usos in vitro ou ex vivo da composição
DE102020114183B4 (de) 2020-05-27 2022-07-14 Universität Leipzig Dezernat Forschung und Transfer Mittel zur transfektion von nukleinsäuren in zellen
CN112195193A (zh) * 2020-09-30 2021-01-08 上海交通大学 单链dna在基因转染中的应用
US20240327830A1 (en) * 2022-02-28 2024-10-03 Northwestern University Dise-inducing srna-polyplexes and srna-lipopolyplexes and methods of using the same to treat cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427394B2 (en) * 2000-10-10 2008-09-23 Massachusetts Institute Of Technology Biodegradable poly(β-amino esters) and uses thereof
US7601367B2 (en) * 2002-05-28 2009-10-13 Mirus Bio Llc Compositions and processes using siRNA, amphipathic compounds and polycations
EP1546173A4 (en) * 2002-08-06 2006-05-31 Intradigm Corp METHOD FOR DOWNSTREGULATING THE EXPRESSION OF TARGET GENES IN VIVO BY INCLUDING INTERFERING RNA
JP2006517793A (ja) * 2003-01-31 2006-08-03 ノバルティス アクチエンゲゼルシャフト スクリーニングアッセイ
JP2007502129A (ja) * 2003-05-09 2007-02-08 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 短鎖干渉ｒｎａライブラリーならびに合成および使用の方法
SG190613A1 (en) * 2003-07-16 2013-06-28 Protiva Biotherapeutics Inc Lipid encapsulated interfering rna
WO2005059111A2 (en) * 2003-12-17 2005-06-30 The Trustees Of Columbia University In The City Of New York DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA
JP2008527993A (ja) * 2005-01-24 2008-07-31 アヴァリス・アクチエボラーグ 特異性及び送達の改善のためのｓｉＲＮＡ分子、ｓｈＲＮＡ分子又はアンチセンス分子及び機能的実体を含む複合体
US20100310670A1 (en) * 2005-09-02 2010-12-09 Takeda Pharmaceutical Company Limited Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
KR100863405B1 (ko) * 2005-09-12 2008-10-14 주식회사 대웅 암 진단 마커 및 이의 이용
JP2007119396A (ja) * 2005-10-28 2007-05-17 Hosokawa Funtai Gijutsu Kenkyusho:Kk 核酸化合物封入ナノ粒子を含む経肺投与用医薬製剤
GB0613753D0 (en) * 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
CN101085356A (zh) * 2007-06-21 2007-12-12 中国科学院长春应用化学研究所 一种非病毒基因转染载体、其与质粒dna复合物颗粒及制备方法和用法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Read, ML. et al. Nucleic Acids Research, 2006, vol.33, no.9, e86

Also Published As

Publication number Publication date
IL206310A (en) 2013-07-31
CN101952434A (zh) 2011-01-19
US20100297756A1 (en) 2010-11-25
KR20100105674A (ko) 2010-09-29
JP5802389B2 (ja) 2015-10-28
WO2009074970A3 (en) 2009-10-29
EP2229445B1 (en) 2012-12-05
JP2011505826A (ja) 2011-03-03
EP2229445A2 (en) 2010-09-22
WO2009074970A2 (en) 2009-06-18
IL206310A0 (en) 2010-12-30
CA2708354C (en) 2018-12-11
CA2708354A1 (en) 2009-06-18
CN101952434B (zh) 2016-11-16

Similar Documents

Publication Publication Date Title
KR101590652B1 (ko) 합성 중합체를 사용하여 유전자 사일런싱에 활성이 있는 핵산을 전달하기 위한 수단
Jeong et al. Reducible poly (amido ethylenimine) directed to enhance RNA interference
AU2009236219B2 (en) Silencing of CSN5 gene expression using interfering RNA
EP2257587B1 (fr) Polymere derive de la polyethylenimine lineaire pour le transfert de gene
US20090068743A1 (en) Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions
JP2011505826A5 (enExample)
JPWO2005078084A1 (ja) ２本鎖オリゴ核酸を担持したポリイオンコンプレックスおよびその製造法とそれを含む医薬組成物
IL293589A (en) Peptide docking vehicle for targeted nucleic acid delivery and uses thereof
EP2552460A1 (en) Polymers for delivering molecules of interest
WO2012090223A1 (en) Poly(ether imine) dendrimers and uses thereof
US20230203491A1 (en) Double-stranded oligonucleotide and composition for treating covid-19 containing same
US20240026051A1 (en) Cationic cyclic amine and amphipathic transfection reagents
US10619162B1 (en) Cationic cyclic amine and amphipathic transfection reagents
HK1149052A (en) Means for delivery of nucleic acids active for gene silencing using synthetic polymers
HK1149052B (en) Means for delivery of nucleic acids active for gene silencing using synthetic polymers
CN115975182B (zh) 一种氨基酸共聚物及其应用
WO2023112872A1 (ja) 核酸送達用担体及び核酸送達複合体
FR3108330A1 (fr) Copolymere lineaire pour la transfection de genes
Lote Synthesis and Evaluation of Oligospermines for Nucleic Acid Delivery

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100713

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20131115

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150324

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20151029

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20160126

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20160126

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20181226

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20181226

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20191226

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20191226

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20230126

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20240116

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20250114

Start annual number: 10

End annual number: 10